News und Analysen

Pfizer (NYSE: PFE) has a huge 7.1% dividend yield. That certainly compares favorably to the broader market's 1.2% yield and the average healthcare stock's yield of 1.7%. But Pfizer's lofty yield

As we enter the final three months of 2025, some investors may be looking for red-hot growth stocks with room to run. Whereas others may be searching for beaten-down stocks at compelling valuations

The GLP-1 market has grabbed considerable attention in the past couple of years, and there's little doubt as to which pharmaceutical companies dominate this space. Eli Lilly is currently the leader

Share price has nothing to do with whether a stock is fairly valued. However, it is nonetheless an important consideration for investors on tight budgets. 

With that in mind, three Fool.com

Cidara Therapeutics (NASDAQ: CDTX) had some encouraging news to deliver at the end of the trading week, and investors traded the biotech's stock up as a result. It closed Friday nearly 7% higher in

Over the last few years, investors have witnessed an unprecedented surge in capital expenditures by big tech companies, which are continuing to pour funds into building out their artificial

In the pharmaceutical world, if you can't develop 'em, acquire 'em. That seems to be the philosophy behind Pfizer's (NYSE: PFE) latest big-ticket buy, specifically its purchase of clinical-stage

It isn't difficult for a modestly priced stock to leap in value on a positive news item. That's the dynamic behind the monster rise these past few days of clinical-stage biotech CytomX Therapeutics

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD), Intel (NASDAQ: INTC), Nvidia (NASDAQ: NVDA), and other semiconductor stocks. To learn more, check out the

Want to invest in some low-priced stocks that possess a lot of upside in the long run? The stocks listed below could be great options for bargain hunters, as each one trades at less than $100 per

Remember Pfizer (NYSE: PFE), the giant pharmaceutical company that developed a COVID-19 vaccine within weeks of the pandemic hitting U.S. shores and got it approved within a year? It was the fastest

AbbVie (NYSE: ABBV) ranks as the third-largest pharmaceutical company in the world, with a market capitalization hovering around $390 billion. It markets around a dozen blockbuster drugs, plus many

Weight loss drugs have represented an enormous growth area for biotech and pharma companies over the past couple of years. Pharma giants Eli Lilly and Novo Nordisk dominate the market with their

In today's video, I discuss recent updates affecting Intel (NASDAQ: INTC), Nvidia (NASDAQ: NVDA), and Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider

The winds of political change have hit the healthcare industry, with drug makers seemingly taking the brunt of the gale. Industry-leading companies like Pfizer (NYSE: PFE), Merck (NYSE: MRK), and

The problem with trying to buy a stock at its low is that you'll only know whether it has bottomed out after it has done so. When it's in the midst of a sell-off, it's impossible to know how low

Pfizer (NYSE: PFE) is highly likely to survive the current headwinds it faces in the pharmaceutical sector. It has a long history and a strong core business. But it isn't the only drugmaker that's

A few years ago, Pfizer (NYSE: PFE) saw revenue soar to record heights thanks to coronavirus-related sales, from its vaccine Comirnaty and its treatment Paxlovid. On top of this, the company's

Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%

Medical device specialist DexCom (NASDAQ: DXCM) has encountered significant headwinds since last year. The company's financial results in 2024 weren't nearly as strong as the market had expected

Shares of a little-known biotechnology stock called Metsera (NASDAQ: MTSR) popped on Monday, Sept. 22, after Pfizer (NYSE: PFE) announced it would be acquiring it for a steep premium. Under the

Strong dividend payers can be a stabilizing force in a well-diversified portfolio. That's because corporations that can consistently pay and raise their payouts over a long period are often

A victory on the regulatory front and a bullish analyst move were the twin news items propelling BioNTech's (NASDAQ: BNTX) shares higher as the stock trading week began on Monday. The Germany-based

Voyager Technologies (NYSE: VOYG), one of a handful of space companies angling to build the next space station to replace the International Space Station, announced today it has acquired privately